{
    "ticker": "OSIS",
    "name": "Osiris Therapeutics, Inc.",
    "description": "Osiris Therapeutics, Inc. is a biotechnology company specializing in regenerative medicine. Founded in 1992, the company is a pioneer in developing and commercializing innovative products to treat medical conditions through the use of stem cells and related technologies. Osiris is best known for its groundbreaking work in developing allogeneic cellular therapies, particularly in the fields of orthopedics, wound care, and inflammation. Its flagship product, Grafix, is a cryopreserved placental membrane that aids in wound healing and is approved for use in various surgical applications. Osiris is committed to advancing the science of regenerative medicine and improving patient outcomes through its research and development efforts. With a robust pipeline of therapies in various stages of clinical development, the company aims to address unmet medical needs and transform the treatment landscape for patients suffering from chronic conditions. Osiris Therapeutics emphasizes the importance of collaboration and strategic partnerships in bringing its innovative products to market, ensuring that its therapies are accessible to patients in need. The company is headquartered in Columbia, Maryland, and continues to focus on expanding its portfolio of regenerative medicine therapies.",
    "industry": [
        "Biotechnology",
        "Regenerative Medicine"
    ],
    "headquarters": "Columbia, Maryland, USA",
    "founded": "1992",
    "website": "https://www.osiristx.com",
    "ceo": "John R. R. Sweeney",
    "social_media": {
        "twitter": "https://twitter.com/OsirisTX",
        "linkedin": "https://www.linkedin.com/company/osiris-therapeutics/"
    },
    "investor_relations": "https://www.osiristx.com/investor-relations",
    "key_executives": [
        {
            "name": "John R. R. Sweeney",
            "position": "CEO"
        },
        {
            "name": "Michael J. McCully",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Cellular Therapies",
            "products": [
                "Grafix",
                "Ovation"
            ]
        },
        {
            "category": "Wound Care",
            "products": [
                "Strattice"
            ]
        }
    ],
    "seo": {
        "meta_title": "Osiris Therapeutics, Inc. | Regenerative Medicine and Cellular Therapies",
        "meta_description": "Explore Osiris Therapeutics, Inc., a leader in regenerative medicine focused on innovative cellular therapies for wound care and orthopedics.",
        "keywords": [
            "Osiris Therapeutics",
            "Regenerative Medicine",
            "Cellular Therapies",
            "Wound Care",
            "Grafix",
            "Stem Cells"
        ]
    },
    "faq": [
        {
            "question": "What is Osiris known for?",
            "answer": "Osiris is known for its development of regenerative medicine products, particularly in wound care and cellular therapies."
        },
        {
            "question": "Who is the CEO of Osiris?",
            "answer": "John R. R. Sweeney is the CEO of Osiris Therapeutics, Inc."
        },
        {
            "question": "Where is Osiris headquartered?",
            "answer": "Osiris is headquartered in Columbia, Maryland, USA."
        },
        {
            "question": "What are Osiris's main products?",
            "answer": "Osiris's main products include Grafix, Ovation, and Strattice."
        },
        {
            "question": "When was Osiris founded?",
            "answer": "Osiris was founded in 1992."
        }
    ],
    "competitors": [
        "AMGN",
        "REGN",
        "BMY",
        "GILD"
    ],
    "related_stocks": [
        "VRTX",
        "ILMN",
        "EDIT",
        "CRSP"
    ]
}